Logo

Ipsogen to Offer Affymetrix-Based Research Services

Jul 23, 2004

NEW YORK, July 23 (GenomeWeb News) - Ipsogen will provide microarray-based services to industrial and academic customers based on Affymetrix's technology, the Marseille, France-based company said today.

 

As an "authorized service provider" for Affymetrix technology, Ipsogen will add Affymetrix's GeneChip system to its research services. The company's services focus on the molecular diagnosis of cancer and the discovery and development of anti-cancer drugs.

Breaking News
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.